Results 41 to 50 of about 27,558 (226)

Thrombophilia testing: Update, guidelines in the greyzones [PDF]

, 2016
Thrombophilien sind hereditäre oder erworbene Krankheitszustände, welche das Risiko für Thromboembolien erhöhen. Eine Thrombophilieabklärung wird häufig bei Patienten mit venösen Thromboembolien (VTE) sowie bei deren Angehörigen durchgeführt.
Nagler, Michael, Angelillo-Scherrer, Anne   +1 more
core   +2 more sources

Assessing the Sensitivity and the Clinical Impact of the 2023 American College of Rheumatology/EULAR Classification Criteria in Obstetric Antiphospholid Syndrome: Findings From a Multicenter Italian Cohort With a Long‐Term Follow‐Up

Arthritis Care &Research, EarlyView.
Objective The aim of this study was to evaluate the sensitivity of the 2023 American College of Rheumatology (ACR)/EULAR classification criteria for antiphospholipid syndrome (APS) in a real‐world cohort of women diagnosed with primary obstetric APS (oAPS) and to assess their ability to identify patients at risk of future pregnancy complications ...
Francesca Ruffilli, Cecilia Nalli, Francesca Crisafulli, Carlo Garaffoni, Marcello Govoni, Giulia Voltarel, Alba C. Pozzi, Beatrice Maranini, Ettore Silvagni, Alessandra Bortoluzzi, Angela Tincani   +10 more
wiley   +1 more source

Diagnostic implications and effective treatment of Susac syndrome with thrombophilia

, 2016
Susac syndrome is an uncommon autoimmune microangiopathy characterized by a combination of encephalopathy, branch retinal artery occlusions (BRAO), and hearing loss.
Ewa Czaplicka, Bogna Grygiel-Górniak, Mariusz Puszczewicz   +2 more
core   +1 more source

The 3’ End Prothrombin Gene Variants in Serbian Patients with Idiopathic Thrombophilia

Balkan Journal of Medical Genetics, 2014
Thrombophilia is a multifactorial disorder that arises from the interaction of acquired and genetic risk factors. Despite the significant efforts made to understand the etiology of this disease, there are still a certain number of patients suffering from
Aradjanski M., Djordjevic V., Pruner I., Tomic B., Gvozdenov M., Kovac M., Radojkovic D.   +6 more
doaj   +1 more source

Cardiovascular toxicity induced by TKIs in patients with chronic myeloid leukaemia: Are women and men different?

ESC Heart Failure, Volume 12, Issue 2, Page 1447-1454, April 2025.
This study analyzes 148 patients (66 women and 82 men) with chronic myeloid leukemia treated with tyrosine kinase inhibitors, focusing on cardiovascular adverse events. The risk assessment, performed using the HFA/ICOS score, reveals sex‐specific differences: venous thrombosis is more common in women, while arterial thrombosis predominates in men.
Cristina Madaudo, Daniela Di Lisi, Antonio Cannatà, Federica Manfrè, Celeste Vullo, Marco Santoro, Ciro Botta, Salvatrice Mancuso, Sergio Siragusa, Alfredo Ruggero Galassi, Giuseppina Novo   +10 more
wiley   +1 more source

Gout in pregnancy: Obstetric and neonatal outcomes

International Journal of Gynecology &Obstetrics, Volume 169, Issue 1, Page 349-355, April 2025.
Abstract Objective The pregnancy, delivery, and neonatal outcomes of pregnancies complicated by gout have yet to be evaluated in a population‐based study. We sought to evaluate the obstetric and neonatal outcomes in pregnant patients with gout using a national population database.
Sam Amar, Ahmad Badeghiesh, Haitham Baghlaf, Michael H. Dahan   +3 more
wiley   +1 more source

Rare vasculitis types and obstetric and neonatal outcomes – A population‐based study

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective Vasculitis is an infrequent pathology among reproductive‐aged women. While data exists regarding pregnancy outcomes in the more common vasculitis subtypes, data is limited regarding these outcomes in rare vasculitis subtypes. We aimed to compare pregnancy and perinatal outcomes between women who suffered from rare types of vasculitis
Uri Amikam, Ahmad Badeghiesh, Haitham Baghlaf, Richard Brown, Michael H. Dahan   +4 more
wiley   +1 more source

Comparative frequency of Coagulation Factor II and Coagulation Factor V Alleles among new-born and senior citizens [PDF]

, 2005
Resistance to activated protein C is one of the most common inherited disorders associated with hereditary thrombophilia. A missense mutation in the gene coding for coagulation factor V (CF V Leiden) and which renders this procoagulant factor resistant ...
Bezzina Wettinger, Stephanie, Scerri, Christian A., Felice, Alex, Abela Medici, Joseph, Grochowska, Alicha   +4 more
core  

The Authors Reply: “Cost and Utility of Thrombophilia Testing”

, 2017
We thank Dr. Berse and colleagues for their correspondence about our paper. We are pleased they agreed with our conclusion: Thrombophilia testing has limited clinical utility in most inpatient settings.No Full ...
Petrilli, CM, Chopra, V, Lauren Heidemann, Heidemann, L, Mack, M, Megan Mack, Christopher M. Petrilli, Paul Durance, Vineet Chopra, Durance, P   +9 more
core   +1 more source

Prevalence and factors associated with high-risk thrombophilia: a single-center cross-sectional study of 3550 patients at a tertiary Thrombosis Centre in Switzerland

Research and Practice in Thrombosis and Haemostasis
Background: Thrombophilia testing remains controversial, with no standardized recommendations across patient populations. Objectives: Given the clinical significance of high-risk thrombophilia (homozygous factor V Leiden or prothrombin G20210A mutations,
Shabnam Najaf Zadeh, Fabienne Schmidli, Katarzyna Aleksandra Jalowiec, Tobias Tritschler, Yan Xu, Alan Haynes, Grégoire Le Gal, Anne Angelillo-Scherrer, Kristina Vrotniakaite-Bajerciene   +8 more
doaj   +1 more source